tiprankstipranks
Cabaletta Bio Advances Clinical Trials with Lonza Partnership
PremiumCompany AnnouncementsCabaletta Bio Advances Clinical Trials with Lonza Partnership
3M ago
Cabaletta Bio announces strategic priorities, anticipated milestones for 2025
Premium
The Fly
Cabaletta Bio announces strategic priorities, anticipated milestones for 2025
3M ago
Cabaletta Bio downgraded at Evercore ISI on lack of financing clarity
Premium
The Fly
Cabaletta Bio downgraded at Evercore ISI on lack of financing clarity
3M ago
Cabaletta Bio Reports Q3 2024 Financial Results
PremiumCompany AnnouncementsCabaletta Bio Reports Q3 2024 Financial Results
4M ago
Cabaletta Bio announces updated clinical data on CABA-201
Premium
The Fly
Cabaletta Bio announces updated clinical data on CABA-201
4M ago
Cabaletta Bio’s Promising Clinical Data on CABA-201
Premium
Company Announcements
Cabaletta Bio’s Promising Clinical Data on CABA-201
4M ago
Cabaletta Bio initiated with a Buy at UBS
PremiumThe FlyCabaletta Bio initiated with a Buy at UBS
6M ago
Cabaletta Bio Outlines Future Trials and Development Strategy
Premium
Company Announcements
Cabaletta Bio Outlines Future Trials and Development Strategy
6M ago
Cabaletta Bio price target lowered to $15 from $25 at Evercore ISI
Premium
The Fly
Cabaletta Bio price target lowered to $15 from $25 at Evercore ISI
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100